Korrespondenz-Adresse

Prof. Dr. Anca Chiriac
Nicolina Medical Center
Dept. of Dermatology
Șoseaua Nicolina, nr. 171 A
RO-700714 Iasi
Email: ancachiriac@yahoo.com

Conflict of Interests

Funding: There was no funding. Conflict of interest statement: The authors declare no conflict of interest. Ethical approvement: The study has been approved by the ethical committee of the Apollonia University, Iasi, Romania

Literatur

1. Tan SY, Poole PS. Hulusi Behçet (1889-1948): Passion for dermatology. Singapore Med J. 2016;57(7):408-9.
2. Zouboulis CC, Kötter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, Keitel W, Stadler R, Wollina U, Proksch E, Söhnchen R, Weber H, Gollnick HP, Hölzle E, Fritz K, Licht T, Orfanos CE. Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J. 1997;38(6):411-22.
3. Alpsoy E. Behçet's disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions. J Dermatol. 2016;43(6):620-32.
4. Zeidan MJ, Saadoun D, Garrido M, Klatzmann D, Six A, Cacoub P. Behçet's disease physiopathology: a contemporary review. Auto Immun Highlights. 2016;7(1):4.
5. Mazzoccoli G, Matarangolo A, Rubino R, Inglese M, De Cata A. Behçet syndrome: from pathogenesis to novel therapies.Clin Exp Med. 2016;16(1):1-12.
6. de Carvalho VO, Abagge KT, Giraldi S, Kamoi TO, Assahide MK, Fillus Neto J, Marinoni LP. Behçet disease in a child--emphasis on cutaneous manifestations.Pediatr Dermatol. 2007; 24(5):E57-62.
7. Baş Y, Seçkin HY, Kalkan G, Takcı Z, Önder Y, Çıtıl R, Demir S, Şahin Ş. Investigation of Behçet's Disease and Recurrent Aphthous Stomatitis Frequency: The Highest Prevalence in Turkey. Balkan Med J. 2016; 33(4):390-5.
8. Ohno S, Aoki K, Sugiura S, Nakayama E, Itakura K, Aizawa M. Letter: HL-A5 and Behçet's disease. Lancet. 1973;2(7842):1383-4.
9. Takeno M. The association of Behçet's syndrome with HLA-B51 as understood in 2021. Curr Opin Rheumatol. 2022;34(1):4-9
10. Hatemi G, Karatemiz G, Yazici H. Behçet's disease: an MHC-I-opathy? Clin Exp Rheumatol. 2017; 35 Suppl 104(2):5.
11. Coit P, Mumcu G, Ture-Ozdemir F, Unal AU, Alpar U, Bostanci N, Ergun T, Direskeneli H, Sawalha AH. Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behçet's disease. Clin Immunol. 2016;169:28-35.
12. Kim DY, Cho S, Choi MJ, Sohn S, Lee ES, Bang D. Immunopathogenic Role of Herpes Simplex Virus in Behçet's Disease. Genet Res Int. 2013;2013:638273.
13. Mehmood N, Low L, Wallace GR. Behçet's Disease - Do Microbiomes and Genetics Collaborate in Pathogenesis? Front Immunol. 2021;12:648341.
14. Choe JY, Park SH, Kim SK. Serum angiopoietin-1 level is increased in patients with Behçet's disease. Joint Bone Spine. 2010;77(4):340-4.
15. Perazzio SF, Andrade LEC, de Souza AWS. Understanding Behçet’s Disease in the Context of Innate Immunity Activation. Front. Immunol. 2020;11:586558.
16. Baş Y, Seçkin HY, Kalkan G, Takcı Z, Önder Y, Çıtıl R, Demir S, Şahin Ş. Investigation of Behçet's Disease and Recurrent Aphthous Stomatitis Frequency: The Highest Prevalence in Turkey. Balkan Med J. 2016;33(4):390-5.
17. Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V. Behçet's syndrome: a critical digest of the 2014-2015 literature. Clin Exp Rheumatol. 2015; 33(6 Suppl 94):S3-14.
18. Lin P, Liang G. Behçet disease: recommendation for clinical management of mucocutaneous lesions. J Clin Rheumatol. 2006;12(6):282-6.
19. Scherrer MA, de Castro LP, Rocha VB, Pacheco L. The dermatoscopy in the skin pathergy testing: case series in patients with suspected Behçet's Disease . Rev Bras Reumatol. 2014 Nov-Dec; 54(6):494-8.
20. Kaneko F, Togashi A, Nomura E, Nakamura K. A New Diagnostic Way for Behcet's Disease: Skin Prick with Self-Saliva. Genet Res Int. 2014;2014:581468.
21. Alpsoy E, Durusoy C, Yilmaz E, Ozgurel Y, Ermis O, Yazar S, Basaran E. Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study. Arch Dermatol. 2002;138:467–471.
22. Davatchi F, Sadeghi Abdollahi B, Tehrani Banihashemi A, Shahram F, Nadji A, Shams H, Chams-Davatchi C. Colchicine versus placebo in Behçet's disease: randomized, double-blind, controlled crossover trial. Mod Rheumatol. 2009;19(5):542-9.
23. Alpsoy E, Leccese P, Emmi G, Ohno S. Treatment of Behçet's Disease: An Algorithmic Multidisciplinary Approach. Front Med (Lausanne). 2021;8:624795
24. Yazici H, Pazarli H, Barnes CG, Tüzün Y, Ozyazgan Y, Silman A, Serdaroğlu S, Oğuz V, Yurdakul S, Lovatt GE, Yazici B, Somani S, Müftüoğlu A. A controlled trial of azathioprine in Behcet's syndrome. N Engl J Med. 1990;322:281–5.
25. Kötter I, Günaydin I, Zierhut M, Stübiger N. The use of interferon alpha in Behçet disease: review of the literature. Semin Arthritis Rheum. 2004;33:320–35.
26. Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S, Zwingenberger K, Yazici H. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1998;128(6):443-50.
27. Fabiani C, Vitale A, Emmi G, Vannozzi L, Lopalco G, Guerriero S, Orlando I, Franceschini R, Bacherini D, Cimino L, Soriano A, Frediani B, Galeazzi M, Iannone F, Tosi GM, Salvarani C, Cantarini L. Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study. Clin Rheumatol. 2017;36(1):183-189.
28. Emmi G, Talarico R, Lopalco G, Cimaz R, Cantini F, Viapiana O, Olivieri I, Goldoni M, Vitale A, Silvestri E, Prisco D, Lapadula G, Galeazzi M, Iannone F, Cantarini L. Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study. Clin Rheumatol. 2016;35(5):1281-6.
29. Cantarini L, Vitale A, Scalini P, Dinarello CA, Rigante D, Franceschini R, Simonini G, Borsari G, Caso F, Lucherini OM, Frediani B, Bertoldi I, Punzi L, Galeazzi M, Cimaz R. Anakinra treatment in drug-resistant Behcet's disease: a case series. Clin Rheumatol. 201534(7):1293-301.
30. Hatemi G, Mahr A, Ishigatsubo Y, Song YW, Takeno M, Kim D, Melikoğlu M, Cheng S, McCue S, Paris M, Chen M, Yazici Y. Trial of Apremilast for Oral Ulcers in Behçet's Syndrome. N Engl J Med. 2019;381(20):1918-28.
31. Tanaka H, Shimizu N, Tougasaki E, Kawajiri C, Hashimoto S, Takeda Y, Sakai S, Takeuchi M, Ohwada C, Sakaida E, Takagi T, Nakaseko C. Successful treatment by azacitidine therapy of intestinal Behçet's disease associated with myelodysplastic syndrome. Int J Hematol. 2013;97(4):520-4.
32. Farzaneh R, Khabbazi A, Soltani-Zangbar MS, Abbasian S, Malek Mahdavi A, Motavalli R, Yousefi M. Effects of nanocurcumin supplementation on T-helper 17 cells inflammatory response in patients with Behcet's disease: a randomized controlled trial. Immunopharmacol Immunotoxicol. 2022;44(2):206-215.
33. Faghfouri AH, Baradaran B, Khabbazi A, Abdoli Shadbad M, Papi S, Faghfuri E, Khajebishak Y, Rahmani S, Tolou Hayat P, Alipour B. Regulation of NLRP3 inflammasome by zinc supplementation in Behçet's disease patients: A double-blind, randomized placebo-controlled clinical trial. Int Immunopharmacol. 2022;109:108825.
34. Takeno M, Dobashi H, Tanaka Y, Kono H, Sugii S, Kishimoto M, Cheng S, McCue S, Paris M, Chen M, Ishigatsubo Y. Apremilast in a Japanese subgroup with Behçet's syndrome: Results from a Phase 3, randomised, double-blind, placebo-controlled study. Mod Rheumatol. 2022;32(2):413-21.
35. Nagieb CS, Harhash TA, Fayed HL, Ali S. Evaluation of diode laser versus topical corticosteroid in management of Behcet's disease-associated oral ulcers: a randomized clinical trial. Clin Oral Investig. 2022;26(1):697-704.
36. Mohammadi M, Shahram F, Shams H, Akhlaghi M, Ashofteh F, Davatchi F. High-dose intravenous steroid pulse therapy in ocular involvement of Behcet's disease: a pilot double-blind controlled study. Int J Rheum Dis. 2017;20(9):1269-76.
37. Lightman S, Taylor SR, Bunce C, Longhurst H, Lynn W, Moots R, Stanford M, Tomkins-Netzer O, Yang D, Calder VL, Haskard DO. Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17. Ann Rheum Dis. 2015;74(6):1138-44.
38. Parvathi-Devi MK, D N S V R, Koppal S, Byatnal AR, Rukmangada T, Byatnal AA. Efficacy of rebamipide and levamisole in the treatment of patients with recurrent aphthous ulcer - a comparative study. J Clin Diagn Res. 2014;8(11):ZC119-22.
38. Chams-Davatchi C, Barikbin B, Shahram F, Nadji A, Moghaddassi M, Yousefi M, Davatchi F. Pimecrolimus versus placebo in genital aphthous ulcers of Behcet's disease: a randomized double-blind controlled trial. Int J Rheum Dis. 201013(3):253-8.

Ausgabe

KOSMETISCHE MEDIZIN 2.25